Global Emergency Contraceptive Pills Market Research Report 2021

Emergency contraceptive pills are remedies that women take to prevent unwanted pregnancies after unprotected sex or within hours or days of contraceptive failure.

The global Emergency Contraceptive Pills market was valued at US$ 954.3 million in 2019 and is expected to reach US$ 1062.6 million by the end of 2026, growing at a CAGR of 1.5% during 2021-2026.
This report focuses on Emergency Contraceptive Pills volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Emergency Contraceptive Pills market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Emergency Contraceptive Pills Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Combination Pills
Progesterone Pills
Estrogen Pills
Others

Segment by Application
Online
Offline

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
HLL Life Care
Pfizer
Syzygy Healthcare
V Care Pharma
Allergan
Lupin
Mankind
Piramal
Teva
Bayer AG
Zhejiang Xianju Pharmaceutical Co

Frequently Asked Questions